Novo Nordisk aware of reports 10 people taking compounded weight-loss drug copies died | Reuters

Nov 07, 2024

Sign up here.

Reporting by Maggie Fick; Editing by Jan Harvey, Emelia Sithole-Matarise and Louise Heavens

Our Standards: The Thomson Reuters Trust Principles., opens new tab

Thomson Reuters

Maggie is a Britain-based reporter covering the European pharmaceuticals industry with a global perspective. In 2023, Maggie's coverage of Danish drugmaker Novo Nordisk and its race to increase production of its new weight-loss drug helped the Health & Pharma team win a Reuters Journalists of the Year award in the Beat Coverage of the Year category. Since November 2023, she has also been participating in Reuters coverage related to the Israel-Hamas war. Previously based in Nairobi and Cairo for Reuters and in Lagos for the Financial Times, Maggie got her start in journalism in 2010 as a freelancer for The Associated Press in South Sudan.

Thomson Reuters

Based in Copenhagen, Jacob oversees reporting from Denmark, Iceland, Greenland and the Faroe Islands. He specializes in security and geopolitics in the Arctic and Baltic Sea regions, as well as large corporates such as obesity drug maker Novo Nordisk, brewer Carlsberg and shipping group Maersk. Before moving to Copenhagen in 2016, Jacob spent seven years in Moscow covering Russia's oil and gas industry for Dow Jones Newswires and The Wall Street Journal, followed by four years in Singapore covering energy markets for WSJ and Reuters.